CivicKnodeCivicKnowA project of CivicKnode
Sign in

HB 1440

Did not advanceCrossfile SB 705
Add to calendar

Maryland Transit Administration - Disabled Reduced Fare Program - Opioid Treatment Program Patients

Sponsor: Melissa Wells (District 40)Committee: Environment and TransportationSubject: Transportation - GenerallyStatus: First Reading Finance (as of Nov 6, 2020)

What this bill does

Official synopsis

Requiring the Maryland Transit Administration to make available to opioid treatment programs monthly transit passes that are for use by patients of opioid treatment programs who qualify for the administration's Disabled Reduced Fare Program and may be issued to patients on site at opioid treatment programs by staff; requiring the passes to be made available at a reduced price that reflects the price of a monthly pass issued under the Disabled Reduced Fare Program as of October 1, 2020; etc.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (6)

MGA witness list
FAV 6Favorable
PositionWitnessOrganizationTestimony
FAVDelegate Wells, Delegate WellslegislatorIndividualOral + Written (PDF)
FAVHarris, AlfredIndividualPosition only
FAVThompson, wayneIndividualPosition only
FAVali, bilalIndividualPosition only
FAVbrocato, BarbaralobbyistIndividualPosition only
FAVpelegrini, andreIndividualPosition only

Registered lobbyists who testified

FAVbrocato, BarbaraRegistered for: Acorn Health; American Physical Therapy Association Maryland - APTA MD; Arthritis & Rheumatism Associates, P.C.; Associates in Radiation Medicine; League for People with Disabilities, The; Maryland Academy of Nutrition and Dietetics